🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)
This product: 320mg
Pygeum africanum Bark Extract
100 mg

Other Ingredients

Gelatin Glycerin Caramel color Titanium Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult Male (18-50 Years) Seniors/Mature (>50 Years) - Men ONLY

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one softgel capsule daily.

⚠️ Warnings & Precautions

Discontinue use two weeks prior to surgery.

KEEP OUT OF REACH OF CHILDREN.

WARNING: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Additional Information

Store in a cool, dry place.

CODE 183703 FLG

Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

NEW

Potencies verified by GNC procedure #5123 and #5363.

Supports Normal Prostate Function and Healthy Urinary Flow*

Product Details

UPC / SKU 0 48107 09717 2
DSLD Entry Date 2011-10-26
Product Type Botanical
Form Softgel Capsule
DSLD ID 867
Data Updated 2026-04-11

Research Evidence

35 Research Sources
52 Avg Quality Score
15 Meta Analysis
11 Systematic Review
7 Rct
1 Narrative Review
1 Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009
View all evidence for Saw Palmetto →

Compare Similar Products

View all Saw Palmetto products →